Correlation Between OmniAb and Pyxis Oncology

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both OmniAb and Pyxis Oncology at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining OmniAb and Pyxis Oncology into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between OmniAb Inc and Pyxis Oncology, you can compare the effects of market volatilities on OmniAb and Pyxis Oncology and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in OmniAb with a short position of Pyxis Oncology. Check out your portfolio center. Please also check ongoing floating volatility patterns of OmniAb and Pyxis Oncology.

Diversification Opportunities for OmniAb and Pyxis Oncology

-0.52
  Correlation Coefficient

Excellent diversification

The 3 months correlation between OmniAb and Pyxis is -0.52. Overlapping area represents the amount of risk that can be diversified away by holding OmniAb Inc and Pyxis Oncology in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Pyxis Oncology and OmniAb is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on OmniAb Inc are associated (or correlated) with Pyxis Oncology. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Pyxis Oncology has no effect on the direction of OmniAb i.e., OmniAb and Pyxis Oncology go up and down completely randomly.

Pair Corralation between OmniAb and Pyxis Oncology

Given the investment horizon of 90 days OmniAb Inc is expected to under-perform the Pyxis Oncology. But the stock apears to be less risky and, when comparing its historical volatility, OmniAb Inc is 1.79 times less risky than Pyxis Oncology. The stock trades about -0.08 of its potential returns per unit of risk. The Pyxis Oncology is currently generating about 0.27 of returns per unit of risk over similar time horizon. If you would invest  123.00  in Pyxis Oncology on July 28, 2025 and sell it today you would earn a total of  223.00  from holding Pyxis Oncology or generate 181.3% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthVery Weak
Accuracy100.0%
ValuesDaily Returns

OmniAb Inc  vs.  Pyxis Oncology

 Performance 
       Timeline  
OmniAb Inc 

Risk-Adjusted Performance

Weakest

 
Weak
 
Strong
Over the last 90 days OmniAb Inc has generated negative risk-adjusted returns adding no value to investors with long positions. Despite unfluctuating performance in the last few months, the Stock's fundamental drivers remain fairly strong which may send shares a bit higher in November 2025. The recent confusion may also be a sign of long-lasting up-swing for the firm traders.
Pyxis Oncology 

Risk-Adjusted Performance

Solid

 
Weak
 
Strong
Compared to the overall equity markets, risk-adjusted returns on investments in Pyxis Oncology are ranked lower than 21 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively unsteady basic indicators, Pyxis Oncology unveiled solid returns over the last few months and may actually be approaching a breakup point.

OmniAb and Pyxis Oncology Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with OmniAb and Pyxis Oncology

The main advantage of trading using opposite OmniAb and Pyxis Oncology positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if OmniAb position performs unexpectedly, Pyxis Oncology can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Pyxis Oncology will offset losses from the drop in Pyxis Oncology's long position.
The idea behind OmniAb Inc and Pyxis Oncology pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Volatility module to check portfolio volatility and analyze historical return density to properly model market risk.

Other Complementary Tools

Sign In To Macroaxis
Sign in to explore Macroaxis' wealth optimization platform and fintech modules
Sync Your Broker
Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors.
Instant Ratings
Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance
Portfolio File Import
Quickly import all of your third-party portfolios from your local drive in csv format
Analyst Advice
Analyst recommendations and target price estimates broken down by several categories